AI Agents for Vascular Surgery Practices: Automating Billing From Endovascular Revascularization to Dialysis Access and Venous Ablation in 2026

Vascular surgery billing is the most coding-dense surgical specialty in medicine. A single lower extremity revascularization encounter can generate 8–12 separately billable line items: selective catheterization by vessel order, diagnostic angiography with interpretation, angioplasty in one territory, stenting in another, atherectomy in a third, embolic protection device deployment, closure device placement, and supervision-and-interpretation charges for each imaging run. Miss one catheterization order, bundle an angiogram that should bill separately, or misapply a vessel territory code, and the practice loses $800–$3,000 on a single case.

The coding density extends across every vascular subspecialty. Dialysis access procedures follow a hierarchical coding structure where the diagnostic fistulogram is bundled into interventional codes but separately billable when performed from a different access site. Carotid endarterectomy and carotid stenting use fundamentally different coding frameworks — open surgery with a 90-day global period versus percutaneous intervention with a 0-day global. Venous ablation requires payer-specific medical necessity documentation that varies by insurer, with denial rates exceeding 30% when the conservative treatment trial or duplex reflux measurements don't meet each payer's individual criteria.

The 2026 environment makes vascular surgery billing harder. CMS's continued emphasis on correct reporting of catheterization codes — with OIG and RAC audits specifically targeting vascular interventional coding — means overcoding risk is real and undercoding lost revenue is equally costly. The 30–40% annual billing staff turnover (HFMA 2026) hits vascular surgery disproportionately because the catheterization hierarchy, vessel territory rules, and CCI bundling edits require a level of anatomic coding knowledge that generic billers don't possess. And the expansion of endovascular techniques into territories that were previously open-surgical-only means the volume of complex multi-vessel interventional cases is increasing faster than practices can train coders to handle them.

AI agents automate every revenue category in vascular surgery billing — from the selective catheterization coding that determines how many separately billable access charges a case generates, to the venous ablation medical necessity documentation that determines whether the procedure is covered at all.

Endovascular Revascularization: Multi-Vessel Interventions and Catheterization Hierarchies

Lower extremity peripheral arterial disease (PAD) is the volume driver for most vascular surgery practices. Endovascular revascularization — angioplasty, stenting, and atherectomy performed through catheter-based access — has replaced open bypass as the first-line treatment for most claudication and critical limb ischemia cases. The coding is organized by vessel territory and intervention type, with strict hierarchical rules that determine what bundles into what.

The Three-Territory Model

Lower extremity endovascular interventions are coded by three vascular territories, each with its own code set:

The critical coding rule: when multiple interventions are performed in the same vessel territory during the same session, only the most comprehensive code is billable. Angioplasty followed by stenting in the same femoral artery is coded as 37230 (stent with transluminal angioplasty), not 37228 + 37236 separately. But when the surgeon performs angioplasty in the femoral territory and stenting in the iliac territory, both interventions are separately billable — 37228 for the femoral angioplasty and 37236 for the iliac stent — because they occur in different vascular territories.

The errors run in both directions. Billers who don't recognize territory boundaries submit the comprehensive single-vessel code when multi-territory separate billing would capture $1,200–$2,500 more per case. Billers who incorrectly unbundle same-territory interventions into separate codes trigger audit flags and recoupment risk. Both patterns are common because the territory distinctions require anatomic knowledge that most billing staff lack.

Selective Catheterization: The Access Charges That Build the Case

Before any intervention, the surgeon advances catheters to the target vessel. Each level of selective catheterization is separately billable:

• 36200 — Non-selective abdominal aortic catheterization: ~$150
• 36245 — Selective first-order arterial catheterization (e.g., common iliac): ~$250
• 36246 — Selective second-order catheterization (e.g., external iliac, common femoral): ~$300
• 36247 — Selective third-order catheterization (e.g., superficial femoral, popliteal): ~$350
• 36248 — Additional second-order or higher catheterization (different vascular family): ~$200

The rule: each catheter position represents a separately billable catheterization code based on the order of the vessel (how many branches from the aorta the catheter traverses). Non-selective aortic access plus first-order common iliac plus second-order external iliac plus third-order SFA generates four separately billable catheterization codes. But when the surgeon uses a retrograde femoral approach and doesn't advance above the common femoral artery, the catheterization charges are limited to 36245 — and submitting 36246 or 36247 for positions the catheter never reached is both incorrect and audit-liable.

Diagnostic angiography adds another layer. When the surgeon performs diagnostic imaging (75710 unilateral, 75716 bilateral) of the lower extremity vasculature during the same session as an intervention, the diagnostic angiography is typically bundled into the interventional code — unless the diagnostic study was performed through a different access site or evaluated a different vascular territory than the one treated. AI agents parse the operative report to determine whether diagnostic angiography was performed in the same or different territory as the intervention, applying the correct bundling rule for each combination.

A five-surgeon vascular practice performing 500 endovascular cases annually that corrects catheterization coding — capturing all documented selective positions while eliminating unbundling errors — recovers an average of $180K per year in previously missed or incorrectly coded access charges.

AI agents read the operative report for every catheter position documented, map each position to the correct order-based catheterization code, validate the vessel territory for each intervention, apply the correct comprehensive code when multiple interventions occur in the same territory, and separately bill interventions in different territories with appropriate modifiers. For practices performing 300–800 endovascular cases annually, correct multi-vessel coding and catheterization capture recovers $120K–$350K.

Dialysis Access: Lifecycle Billing From Creation Through Maintenance and Revision

Dialysis access management is a major revenue center for vascular surgery practices, with each access patient generating recurring procedural and surveillance revenue across years of hemodialysis. The coding follows a hierarchical structure that bundles diagnostic imaging into interventional procedures — but only when both are performed through the same access site during the same session.

Access Creation: AV Fistula and AV Graft Coding

Initial dialysis access creation uses open surgical codes with 90-day global periods:

The billing errors in access creation center on two patterns. First, practices that use generic code 36821 for all fistula types — including basilic vein transpositions that should be coded as 36818 or 36819 at higher reimbursement — leave $400–$600 per case unbilled. Second, practices that don't capture intraoperative duplex assessment (93990) when performed during the access creation — or that don't apply the correct -26/-TC professional-technical component split when the vascular lab provides the technical component — miss $80–$150 per case.

Access Maintenance: The Interventional Hierarchy

Dialysis access complications — stenosis, thrombosis, and pseudoaneurysm — drive a high volume of interventional procedures. The coding follows a strict hierarchy where the diagnostic fistulogram (36901) is bundled into all interventional codes when performed through the same access site:

• 36901 — Diagnostic fistulogram (dialysis circuit, including the arterial anastomosis through the outflow vein): ~$400
• 36902 — Fistulogram with transluminal angioplasty of the peripheral segment: ~$1,200 (includes 36901)
• 36903 — Fistulogram with transluminal angioplasty of the central segment: ~$1,200 (includes 36901)
• 36904 — Percutaneous transluminal mechanical thrombectomy (including thrombolytic injections): ~$1,800 (includes 36901)
• 36905 — Thrombectomy with transluminal angioplasty, peripheral segment: ~$2,200 (includes 36901 + 36902)
• 36906 — Thrombectomy with transluminal angioplasty, central segment: ~$2,200 (includes 36901 + 36903)

The critical rule: 36901 (diagnostic fistulogram) is bundled into 36902–36906 when performed from the same access site during the same session. But when the surgeon performs the fistulogram from one access site (e.g., the arterial limb) and the intervention from a different access site (e.g., direct venous puncture), the diagnostic study is separately billable. Billers who always bundle the fistulogram — even when the operative report documents separate access sites — leave $400 per case unbilled on cases where separate billing is appropriate.

Additionally, when both peripheral and central segment angioplasty are performed during the same session (both 36902 and 36903), both codes are billable because they target different segments of the dialysis circuit. Billers who submit only the single most comprehensive code — assuming same-session bundling — miss $800–$1,200 per case on dual-segment interventions.

AI agents parse the operative report for the specific access site used for the fistulogram versus the intervention, apply the correct bundling rule based on same-site versus different-site access, identify dual-segment interventions that generate two separately billable codes, and track each patient's access history across encounters for revision and replacement coding. For practices managing 200–500 dialysis access patients, correct lifecycle billing and interventional coding recovers $80K–$200K annually.

Carotid Procedures: CEA vs CAS and the Authorization Divide

Carotid artery disease generates two fundamentally different coding frameworks depending on the treatment approach — open carotid endarterectomy (CEA) or percutaneous carotid artery stenting (CAS). The two approaches use different code families, different global periods, different modifier rules, and different authorization requirements.

Carotid Endarterectomy (Open)

CEA (35301) carries a 90-day global period and bundles several components that billers sometimes attempt to bill separately:

• 35301 — Carotid endarterectomy: ~$1,800
• 35390 — Patch angioplasty (separately billable when documented): ~$500
• Shunt insertion — Included in 35301, not separately billable
• Intraoperative completion angiography — Included in 35301 when performed for the treated vessel
• Co-surgeon — Modifier -62 when two surgeons jointly perform the endarterectomy

The common error: billers who don't capture patch angioplasty (35390) when the surgeon applies a patch graft to close the arteriotomy leave $500 per case unbilled. In many practices, the majority of CEAs include patch closure — making this a consistent revenue leak across dozens of cases per year.

Carotid Artery Stenting (Percutaneous)

CAS uses a different code structure with a 0-day global period:

• 37215 — Carotid stenting with distal embolic protection: ~$2,200
• 37216 — Carotid stenting without distal embolic protection: ~$2,000
• 37217 — Carotid stenting with post-stent angioplasty: ~$2,400
• 36222–36224 — Selective catheterization of the carotid artery (first, second, third order): $200–$400 each
• 36228 — Selective catheterization of each intracranial branch (e.g., middle cerebral): ~$250

Catheterization charges for CAS are separately billable and represent a significant revenue component. The typical CAS case generates 2–3 selective catheterization codes (common carotid 36222, internal carotid 36223, and vertebral or contralateral carotid 36224/36228 when evaluated) at $200–$400 each. Billers who don't capture catheterization charges for CAS — incorrectly assuming they're bundled into the stenting code — leave $400–$800 per case unbilled.

The authorization divide is equally important. Most payers cover CEA without prior authorization for symptomatic carotid stenosis ≥50% or asymptomatic stenosis ≥60–70%. CAS, however, typically requires prior authorization — and many payers restrict CAS coverage to patients who are at high surgical risk for CEA (e.g., prior neck radiation, contralateral carotid occlusion, recurrent stenosis after prior CEA, severe cardiac or pulmonary comorbidity). Practices that schedule CAS without verifying that the patient meets the payer's high-surgical-risk criteria face denial rates of 20–35% on CAS cases.

AI agents apply the correct coding framework based on the operative approach, capture patch angioplasty (35390) for CEA cases, bill all documented selective catheterization codes for CAS cases, manage the 90-day global period for CEA versus the 0-day global for CAS, and verify payer-specific CAS coverage criteria — including high-surgical-risk documentation — before the case is scheduled. For practices performing 100–300 carotid procedures annually, correct approach-specific coding and authorization management recovers $60K–$150K.

Venous Ablation: Medical Necessity Documentation That Determines Coverage

Endovenous ablation — radiofrequency (36475/36476), laser (36478/36479), or mechanochemical (36473/36474) — treats superficial venous reflux (varicose veins with chronic venous insufficiency). Venous ablation is one of the highest-volume procedures in vascular surgery and one of the most frequently denied, because payers impose strict medical necessity criteria that vary by insurer.

The Three Medical Necessity Gates

Virtually all commercial payers require three elements for venous ablation coverage:

1. Documented venous reflux on duplex ultrasound: Most payers require reflux duration exceeding 0.5 seconds (some require >1.0 seconds) in the great saphenous vein (GSV), small saphenous vein (SSV), or accessory saphenous vein, measured in the standing position with augmentation. The ultrasound report must document the specific vein, diameter, and reflux duration.
2. Conservative treatment trial: 6–12 weeks (payer-dependent) of graduated compression stocking use (typically 20–30 mmHg or higher) with documented failure. "Failure" means persistent symptoms despite compliance. Payers increasingly require documentation of stocking prescription, fitting, and follow-up visit confirming continued symptoms.
3. Symptomatic venous insufficiency: Clinical documentation must show symptoms beyond cosmetic concern — pain, aching, heaviness, swelling, skin changes (hyperpigmentation, lipodermatosclerosis), or active venous ulceration. CEAP classification C2–C6 is typically required; C1 (telangiectasias/reticular veins only) is classified as cosmetic by most payers.

Practices that submit venous ablation claims without all three documented elements see denial rates of 25–40%. The most common gap: the duplex ultrasound report documents "reflux present" without specifying duration in seconds, or documents reflux in the supine position rather than the standing position required by the payer. The second most common gap: compression stockings were prescribed but no follow-up visit documents the patient's compliance and continued symptoms.

Multi-Session Venous Treatment: Adjunctive Procedures

Venous ablation is frequently performed in conjunction with adjunctive procedures that are separately billable:

• 36465/36466 — Injection sclerotherapy, non-compounded agent (first vein, additional veins): ~$200–$350
• 36468/36470/36471 — Injection sclerotherapy of spider veins or incompetent veins: ~$150–$300
• 37765/37766 — Stab phlebectomy (first 20 incisions, each additional 20): ~$400–$600
• 37785 — Ligation, division, and stripping of short saphenous vein: ~$500

Many payers require that ablation and phlebectomy be performed on separate dates of service (typically 4–6 weeks apart). Practices that perform both on the same day and submit both codes face bundling denials. Conversely, practices that perform them on separate days but don't capture the phlebectomy charge — treating it as a minor follow-up procedure — leave $400–$600 per case unbilled.

AI agents verify that every venous ablation case meets the payer's specific medical necessity criteria before the procedure is scheduled — confirming reflux duration, compression trial documentation, and symptomatic classification. AI applies the correct code based on ablation modality (RF 36475/36476, laser 36478/36479, mechanochemical 36473/36474), captures separately billable adjunctive procedures on appropriate dates of service per payer rules, and tracks the multi-session treatment plan across encounters. For practices performing 300–800 venous ablation cases annually, correct medical necessity documentation and multi-session coding recovers $50K–$120K.

Vascular Laboratory: Duplex Ultrasound and Component Billing

Most vascular surgery practices operate an accredited vascular laboratory that performs arterial and venous duplex ultrasound studies. The vascular lab generates significant revenue — but only when component billing is handled correctly.

Arterial and Venous Duplex Studies

The component billing challenge: when the vascular surgeon performs both the professional interpretation (-26) and the practice owns the equipment and employs the sonographer (technical component, -TC), the practice bills the global code (no modifier) and captures both components. When the practice sends patients to an external vascular lab for the technical component, the surgeon bills only the professional component (-26). Practices that bill the global code when they only performed the professional interpretation — or that bill only -26 when they own the lab and should bill global — create either compliance risk or revenue leakage.

Duplex volume is substantial. A vascular surgery practice with an active vascular lab performs 2,000–5,000 duplex studies annually across pre-operative assessment, post-operative surveillance, and ongoing vascular disease monitoring. At $140–$220 per study (global), the vascular lab represents $300K–$1.1M in annual revenue. Component billing errors that affect even 10–15% of studies create $40K–$100K in annual revenue impact.

AI agents validate whether each duplex study should be billed as global, professional only (-26), or technical only (-TC) based on where the study was performed and who provided interpretation. AI captures the correct bilateral vs unilateral code based on the examination documentation, prevents downcoding from complete (93925) to limited (93926) when the full bilateral protocol was performed, and flags studies performed during the global period of a prior procedure that may require modifier -79 or documentation of medical necessity for the separate diagnostic study. For practices operating a vascular laboratory, correct component billing and complete-vs-limited code selection recovers $40K–$100K annually.

Open Vascular Surgery: Global Periods and Concomitant Procedure Capture

Open vascular surgery — bypass grafting, endarterectomy, aneurysm repair, and embolectomy — generates high per-case reimbursement with 90-day global periods that create both opportunity and risk for subsequent billing.

Lower Extremity Bypass: Coding by Graft Type and Target Vessel

• 35556 — Femoral-popliteal bypass, vein graft: ~$2,200
• 35566 — Femoral-anterior tibial/posterior tibial/peroneal bypass, vein graft: ~$2,800
• 35583 — In-situ vein bypass, femoral-popliteal: ~$2,500
• 35585 — In-situ vein bypass, femoral-tibial: ~$3,000
• 35656 — Femoral-popliteal bypass, synthetic graft: ~$1,800
• 35666 — Femoral-tibial bypass, synthetic graft: ~$2,200

The coding distinction between vein graft and synthetic graft changes reimbursement by $400–$600 per case. Billers who default to the synthetic graft code when the surgeon used autogenous vein — or who don't differentiate between in-situ and reversed vein techniques — consistently undercode these high-value procedures. Additionally, concomitant procedures performed during bypass surgery are separately billable with appropriate modifiers:

• 35685 — Vein patch or cuff at distal anastomosis (separately billable add-on): ~$400
• 35682 — Bypass revision with vein interposition: ~$600
• 35761 — Exploration, not followed by surgical repair (separately billable when documented): ~$500
• 35875/35876 — Thrombectomy of bypass graft, arterial/venous: ~$800

For aortic and iliac procedures, the coding complexity increases further. Aortobifemoral bypass (35646, ~$3,500), aortic aneurysm repair (35081/35082 open, 34701–34713 endovascular EVAR), and iliac endarterectomy (35351/35355/35361/35363) each carry distinct coding rules, concomitant procedure capture opportunities, and modifier requirements. Endovascular aortic repair (EVAR) codes now include distinct codes for infrarenal (34701/34702), aortomonoiliac (34703/34704), and aorto-aortic tube (34705/34706) configurations — and add-on codes for extension prostheses (34708/34709/34710/34711/34712/34713) that many billers don't capture.

AI agents match each open vascular procedure to the correct code based on the graft type (vein vs synthetic, in-situ vs reversed), target vessel, and surgical approach documented in the operative report. AI captures all separately billable concomitant procedures, applies the correct add-on codes for EVAR extension prostheses, and manages the 90-day global period across postoperative surveillance visits and subsequent interventions. For practices performing 200–500 open vascular cases annually, correct graft-type coding and concomitant procedure capture recovers $60K–$150K.

What AI Billing Automation Looks Like in a Vascular Surgery Practice

AI agents for vascular surgery practices integrate with the practice's EHR and PM system and run continuously across every encounter type:

1. Pre-procedure: AI verifies medical necessity documentation for venous ablation (reflux duration, compression trial, symptom classification), confirms CAS high-surgical-risk criteria, and validates prior authorization status for all procedures requiring payer approval
2. Per endovascular case: AI reads the operative report, maps every catheter position to the correct order-based catheterization code, identifies all intervention types and vessel territories, applies the correct comprehensive code for same-territory interventions, and separately bills different-territory interventions with appropriate modifiers
3. Per open vascular case: AI matches the operative technique to the correct graft-type and target-vessel code, captures concomitant procedures and add-on codes, initiates 90-day global period tracking, and validates modifier application for subsequent procedures within the global window
4. Dialysis access tracking: AI monitors each access patient's lifecycle — creation, maturation surveillance, interventional maintenance, revision — applying the correct hierarchical bundling rules and capturing dual-segment interventions as separate billings
5. Vascular laboratory: AI validates component billing (global vs -26 vs -TC) for every duplex study, selects complete vs limited codes based on examination documentation, and flags studies requiring medical necessity justification within global periods
6. Monthly: AI audits catheterization coding accuracy, reconciles global period windows, identifies venous ablation patients approaching their adjunctive phlebectomy window, and produces a dialysis access intervention pipeline report

Deployment takes 3–6 weeks. The first phase connects to the EHR and PM system, maps the active patient panel by procedure type, and runs a retrospective audit of the prior 90 days to quantify current revenue leakage. Most practices see the first measurable impact — correct catheterization capture and venous ablation medical necessity validation — within 30 days.

The Financial Case: What Vascular Surgery Practices Recover

For a practice with 3–8 vascular surgeons performing 1,000–3,000 procedural cases annually, the annual revenue recovery from AI billing automation breaks down:

The ROI calculation is direct. AI billing automation costs a fraction of the salary for one vascular surgery-trained coder ($60K–$80K plus benefits) and eliminates the specialty-specific expertise gap that makes vascular coding staff among the most difficult to recruit in healthcare. The catheterization hierarchy alone — the single coding area that generates the largest per-case revenue variation in vascular surgery — moves from an error-prone manual lookup to an automated anatomic mapping against each documented catheter position. Practices that automate catheterization coding see their per-case endovascular capture increase by $400–$800 within the first 60 days. Most practices reach full ROI within the first quarter.